Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Neoplasms

Explore clinical trials studying Urinary Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

1,199 public trials 263 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Neoplasms trial results

Active, Not Recruiting

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)

NCT04241185

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +8 more
Locations
  • Washington Cancer Institute at MedStar Washington Hospital Center ( Site 0041) Washington D.C., District of Columbia, United States
  • Bay Pines VA Medical Center ( Site 0055) Bay Pines, Florida, United States
  • AdventHealth Orlando-AdventHealth Medical Group Hematology & Oncology at Orlandoc ( Site 0004) Orlando, Florida, United States
  • Norton Cancer Institute ( Site 0044) Louisville, Kentucky, United States
View all 134 locations
View Trial Details
Active, Not Recruiting

A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)

NCT05327530

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • Beacon Cancer Care Coeur d'Alene, Idaho, United States
  • University of Kansas Medical Center Research Institute, Inc. - 3901 Rainbow (MAIN) Kansas City, Kansas, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • The Johns Hopkins Hospital Baltimore, Maryland, United States
View all 97 locations
View Trial Details
Active, Not Recruiting

A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer

NCT04917809

Conditions
Bladder Cancer, Carcinoma, FGFR3 Gene Mutation, +15 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer

NCT03661320

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations
  • Local Institution - 0022 Tucson, Arizona, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • Local Institution - 0021 Littleton, Colorado, United States
  • Local Institution - 0036 Pensacola, Florida, United States
View all 172 locations
View Trial Details
Active, Not Recruiting

BladMetrix Urine Test for Monitoring Recurrence in Non-Muscle Invasive Bladder Cancer

NCT07511517

Conditions
Carcinoma, Carcinoma, Transitional Cell, Bladder, Female Urogenital Diseases, +15 more
Locations
  • Haukeland University Hospital Bergen, Norway
  • Akershus University Hospital (Ahus) Lørenskog, Norway
  • Oslo University Hospital - Aker Oslo, Norway
  • University Hospital of North Norway (UNN) Tromsø, Norway
View Trial Details

Related conditions